The FDA OKs 5 blockbusters in slow start to 2013 drug approvals
Few productivity metrics in biopharma measure up to the annual rate of new drug approvals. So now that the FDA has come through with only 13 novel approvals in the first half of the year, well off the pace of 39 new approvals in 2012, there's some handwringing going on. But it's not as bad as it may appear at first glance.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063